Attending Kidney Week 2017?
RSVP now to get the first look at a ground-breaking approach to treat bloodstream infections in dialysis patients.
The Seraph® Blood Filter is designed to remove drug-resistant and drug-susceptible pathogens from whole blood – including a broad range of bacteria, toxins and viruses.
Seraph received an Expedited Access Pathway designation from the FDA in August of 2017 and clinical trials are evaluating the treatment in dialysis patients.
Please join our the first-ever presentation of interim clinical results on Seraph’s potential to reinvent the treatment of bloodstream infections.
Clinical Experience Treating Bacteremia with a Broad-Spectrum Sorbent Hemoperfusion Device During Dialysis
Wednesday Nov. 1st
6:00PM to 8:00PM
New Orleans Downtown Sheraton
Hors d'oeuvres & Drinks Served.
Please also visit us at our booth #1334.
The Seraph Microbind Affinity Blood Filter is undergoing clinical investigation and is not available for commercial sale.
Seraph® Microbind® Affinity Blood Filter
A simple, rapid treatment for bloodstream infections.